1 results match your criteria: "The PLA Navy Anqing Hospital No. 150 Shuangjing Street[Affiliation]"
Effect of bevacizumab plus paclitaxel and carboplatin regimen on prognostic survival of ovarian cancer patients.
Am J Transl Res
December 2022
Oncology Department, The PLA Navy Anqing Hospital No. 150 Shuangjing Street, Yingjiang District, Anqing 246002, Anhui, China.
Objective: To investigate the efficacy of bevacizumab, paclitaxel and carboplatin in the treatment of ovarian cancer (OC) and the impact on patients' prognosis.
Methods: A total of 90 patients with OC treated at our institution were enrolled in this retrospective analysis. Among them, 30 patients treated with bevacizumab plus paclitaxel and carboplatin regimen were classified as an observation group (OG), and 60 other patients who received paclitaxel and carboplatin were assigned as a control group (CG).